0,964  0,001  Pneumotoxic
0,938  0,002  Muscle relaxant
0,937  0,002  Skeletal muscle relaxant
0,853  0,005  Antileukemic
0,847  0,004  Spasmolytic
0,829  0,003  Cardiodepressant
0,808  0,005  Prostate cancer treatment
0,758  0,013  Antineoplastic (breast cancer)
0,759  0,022  Apoptosis agonist
0,735  0,005  Vasodilator, peripheral
0,690  0,019  Antineoplastic (lung cancer)
0,668  0,003  Acetylcholine nicotinic antagonist
0,647  0,004  Anesthetic general
0,646  0,007  Histamine release inhibitor
0,649  0,010  5 Hydroxytryptamine release stimulant
0,654  0,025  Transcription factor NF kappa B inhibitor
0,586  0,005  P-glycoprotein inhibitor
0,577  0,005  Antiseptic
0,559  0,005  Antineoplastic (liver cancer)
0,555  0,005  Sigma receptor agonist
0,526  0,002  Calcium antagonist
0,523  0,003  Neuronal nicotinic receptor antagonist
0,499  0,023  Radioprotector
0,497  0,023  Cardioprotectant
0,477  0,016  Tumour necrosis factor alpha release inhibitor
0,471  0,014  Vasodilator
0,457  0,003  Nicotinic receptor alpha3 subunit antagonist
0,478  0,029  CYP2D6 substrate
0,462  0,013  Sedative
0,451  0,006  Dopamine antagonist
0,447  0,004  Dopamine D1 antagonist
0,452  0,027  Antineoplastic (pancreatic cancer)
0,423  0,007  Cholinergic antagonist
0,423  0,007  Acetylcholine antagonist
0,464  0,050  Antiparkinsonian
0,410  0,007  Dopamine D2 antagonist
0,424  0,024  Antipyretic
0,402  0,011  DNA methylase inhibitor
0,403  0,011  5 Hydroxytryptamine antagonist
0,394  0,005  Dopamine agonist
0,402  0,023  Antimitotic
0,420  0,041  Respiratory analeptic
0,415  0,040  Caspase 3 stimulant
0,414  0,050  Antineoplastic (colorectal cancer)
0,437  0,075  Alzheimer's disease treatment
0,366  0,005  Alpha 2 adrenoreceptor antagonist
0,412  0,056  CYP2C19 inhibitor
0,364  0,008  Toxic, respiratory center
0,379  0,023  Antineoplastic enhancer
0,393  0,046  Hepatic disorders treatment
0,351  0,005  Opioid kappa receptor antagonist
0,395  0,051  Antineoplastic (colon cancer)
0,391  0,055  Antiprotozoal (Plasmodium)
0,347  0,012  Alpha adrenoreceptor antagonist
0,395  0,065  Antineoplastic (myeloid leukemia)
0,329  0,016  Tubulin antagonist
0,331  0,018  Antineoplastic (squamous cell carcinoma)
0,409  0,106  Caspase 9 stimulant
0,348  0,045  Hypoxia-inducible factor 1 alpha inhibitor
0,303  0,004  Dopamine D2 agonist
0,330  0,035  Psychostimulant
0,385  0,091  Analgesic
0,317  0,026  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,311  0,022  Male reproductive disfunction treatment
0,337  0,061  Antineoplastic (ovarian cancer)
0,300  0,029  5 Hydroxytryptamine 1E antagonist
0,285  0,015  Antiadrenergic
0,275  0,008  Alpha 2c adrenoreceptor antagonist
0,313  0,048  Free radical scavenger
0,274  0,015  Adrenaline antagonist
0,264  0,006  Polo-like kinase-4 inhibitor
0,258  0,004  Nicotinic receptor alpha7 subunit antagonist
0,293  0,040  Antiarrhythmic
0,253  0,005  Electron transport complex I inhibitor
0,253  0,007  Analgesic, opioid
0,250  0,009  Constipation treatment
0,249  0,009  Alpha 2a adrenoreceptor antagonist
0,257  0,018  LDLR expression enhancer
0,264  0,025  Cholinergic
0,242  0,004  Dopamine D5 antagonist
0,306  0,071  Analeptic
0,245  0,015  Alpha 1 adrenoreceptor antagonist
0,244  0,015  Alpha 2b adrenoreceptor antagonist
0,294  0,069  CYP2C19 substrate
0,328  0,105  Antiprotozoal
0,255  0,040  UGT2B7 substrate
0,225  0,010  Opioid antagonist
0,263  0,049  Antiparkinsonian, rigidity relieving
0,231  0,017  Butyrylcholinesterase inhibitor
0,296  0,084  Antineoplastic (brain cancer)
0,233  0,024  Acetylcholinesterase inhibitor
0,251  0,043  Hepatoprotectant
0,212  0,005  Histamine N-methyltransferase inhibitor
0,227  0,022  5 Hydroxytryptamine 2B antagonist
0,273  0,069  DNA damaging
0,302  0,099  CYP3A4 substrate
0,231  0,029  Erectile dysfunction treatment
0,260  0,059  Tyrosine 3 hydroxylase inhibitor
0,219  0,019  Antinephritic
0,284  0,085  Antidepressant
0,206  0,008  Opioid mu receptor antagonist
0,275  0,081  Antineoplastic (melanoma)
0,285  0,092  AR expression inhibitor
0,194  0,004  Antibiotic Glycopeptide-like
0,264  0,076  UGT1A9 substrate
0,205  0,017  Antiprotozoal (Amoeba)
0,199  0,012  5 Hydroxytryptamine 7 antagonist
0,201  0,017  5 Hydroxytryptamine 1 antagonist
0,200  0,016  Alpha 1a adrenoreceptor antagonist
0,192  0,011  Phosphodiesterase I inhibitor
0,268  0,093  Nootropic
0,176  0,005  Opioid kappa receptor agonist
0,239  0,072  Potassium channel (Voltage-sensitive) blocker
0,193  0,027  Antitussive
0,180  0,014  Opioid delta receptor antagonist
0,171  0,005  Opioid mu receptor agonist
0,182  0,016  5 Hydroxytryptamine 1A antagonist
0,174  0,010  Sigma receptor antagonist
0,230  0,068  Dependence treatment
0,239  0,079  Antineoplastic (glioma)
0,163  0,004  Potassium channel small-conductance Ca-activated blocker
0,270  0,114  Vasodilator, coronary
0,162  0,006  Opioid agonist
0,197  0,041  UGT2B9 substrate
0,199  0,044  Antiviral (Influenza A)
0,265  0,113  Apoptosis antagonist
0,215  0,065  Antiviral (Influenza)
0,167  0,019  Breast cancer-resistant protein inhibitor
0,211  0,064  Nitric oxide antagonist
0,237  0,091  Antioxidant
0,250  0,104  CYP2D6 inhibitor
0,192  0,047  Antineoplastic (carcinoma)
0,180  0,035  5 Hydroxytryptamine 2 antagonist
0,150  0,010  Calcium channel L-type blocker
0,185  0,045  Anesthetic
0,155  0,015  5 Hydroxytryptamine 1F antagonist
0,251  0,113  Mood disorders treatment
0,212  0,074  Antialcoholic
0,235  0,097  5 Hydroxytryptamine uptake stimulant
0,242  0,105  CYP1A2 substrate
0,138  0,003  Prolactin release inhibitor
0,222  0,088  Antineoplastic (cervical cancer)
0,154  0,021  Prolactin inhibitor
0,133  0,005  Phosphodiesterase 1A inhibitor
0,153  0,026  Antiviral (Influenza B)
0,185  0,059  UGT1A3 substrate
0,210  0,086  Potassium channel blocker
0,149  0,026  Multidrug resistance-associated protein 1 inhibitor
0,149  0,027  5 Hydroxytryptamine 2C antagonist
0,164  0,045  Cocaine dependence treatment
0,129  0,010  Narcotic antagonist
0,146  0,029  Antineoplastic alkaloid
0,215  0,104  Antineoplastic (sarcoma)
0,142  0,033  AMP-activated protein kinase stimulant
0,205  0,097  Antiprotozoal (Leishmania)
0,118  0,010  5 Hydroxytryptamine 6 antagonist
0,135  0,030  Uric acid excretion stimulant
0,252  0,148  CYP2C9 substrate
0,135  0,032  5 Hydroxytryptamine 2A antagonist
0,234  0,132  CYP3A4 inhibitor
0,160  0,060  Antiparkinsonian, tremor relieving
0,121  0,023  Tocolytic
0,183  0,085  VEGF expression inhibitor
0,110  0,016  Dopamine uptake inhibitor
0,115  0,021  Dopamine D3 antagonist
0,163  0,070  Uterine stimulant
0,280  0,189  5 Hydroxytryptamine release inhibitor
0,177  0,086  UDP-glucuronosyltransferase substrate
0,100  0,009  Potassium channel (Ca-activated) blocker
0,098  0,008  Nicotinic receptor alpha4 subunit antagonist
0,127  0,037  Toll-Like receptor 4 antagonist
0,204  0,119  Antipsychotic
0,255  0,173  Antibacterial
0,174  0,093  UGT1A1 substrate
0,090  0,009  5 Hydroxytryptamine 7 agonist
0,134  0,055  Acetylcholine muscarinic antagonist
0,094  0,017  Uterine relaxant
0,093  0,018  5 Hydroxytryptamine 2A agonist
0,148  0,074  Antidiarrheal
0,098  0,034  Phosphodiesterase 11A inhibitor
0,098  0,034  Phosphodiesterase XI inhibitor
0,203  0,142  Antihypoxic
0,186  0,126  Antihypotensive
0,097  0,037  Antiprotozoal activity enhancer
0,089  0,030  Dopamine D4 antagonist
0,064  0,005  Liver X receptor alpha antagonist
0,102  0,043  Restless leg syndrome treatment
0,133  0,074  Calcium channel blocker
0,088  0,030  5 Hydroxytryptamine 1B antagonist
0,111  0,055  Nav1.1 sodium channel blocker
0,093  0,038  Alpha 1b adrenoreceptor antagonist
0,092  0,038  Nicotinic alpha4beta2 receptor antagonist
0,158  0,104  Septic shock treatment
0,071  0,019  5 Hydroxytryptamine 2 agonist
0,061  0,009  Opioid delta receptor agonist
0,089  0,038  Acetylcholine M4 receptor antagonist
0,058  0,008  Liver X receptor antagonist
0,069  0,021  Dopamine transporter inhibitor
0,068  0,020  Ryanodine receptor antagonist
0,131  0,083  Protein kinase stimulant
0,052  0,004  Dopamine D1 agonist
0,139  0,093  Mutagenic
0,117  0,071  Alkylator
0,070  0,028  Alpha 1 adrenoreceptor agonist
0,061  0,024  5 Hydroxytryptamine 1A agonist
0,057  0,021  Factor III inhibitor
0,078  0,042  5 Hydroxytryptamine agonist
0,099  0,065  Bronchodilator
0,061  0,030  Alpha tubulin antagonist
0,067  0,036  Alpha 1d adrenoreceptor antagonist
0,115  0,085  Antismoking
0,091  0,063  Protein kinase C zeta inhibitor
0,070  0,045  Alpha adrenoreceptor agonist
0,097  0,072  Expectorant
0,100  0,077  Antihypermotility
0,057  0,034  5 Hydroxytryptamine 1 agonist
0,041  0,021  Vesicle monoamine transporter inhibitor
0,137  0,117  Tumour necrosis factor antagonist
0,140  0,121  Antineoplastic (gastric cancer)
0,054  0,035  5 Hydroxytryptamine 1B agonist
0,089  0,072  Alpha 2d adrenoreceptor antagonist
0,063  0,046  5 Hydroxytryptamine 1D antagonist
0,078  0,062  ALK inhibitor
0,056  0,043  5 Hydroxytryptamine 5 antagonist
0,058  0,045  Alpha 2 adrenoreceptor agonist
0,121  0,107  Acetylcholine M1 receptor antagonist
0,130  0,118  Cystic fibrosis treatment
0,084  0,072  Antischistosomal
0,167  0,156  Cardiotonic
0,088  0,077  Dementia treatment
0,038  0,028  5 Hydroxytryptamine 2B agonist
0,058  0,049  5 Hydroxytryptamine 5A antagonist
0,085  0,076  Vascular dementia treatment
0,152  0,143  NOS2 expression inhibitor
0,097  0,089  Topoisomerase II inhibitor
0,017  0,009  NMDA receptor phencyclidine site antagonist
0,038  0,031  Dopamine D5 agonist
0,131  0,124  Amyloid beta aggregation inhibitor
0,028  0,024  Nicotinic alpha3beta4 receptor agonist
0,063  0,060  Phosphodiesterase V inhibitor
0,089  0,088  UGT2B1 substrate
0,049  0,047  Beta tubulin antagonist
0,151  0,150  Cyclic AMP phosphodiesterase inhibitor

